What is ACM Research's operating income?

ACM Research's total operating income in 2025 was $109.43 million, based on the following breakdown: Total Gross Profit: $400.07 million Total Operating Expenses: $290.64 million

ACM Research (ACMR) Financials

$79.61 +0.51 (+0.64%)

As of 01:46 PM Eastern

Compare

Annual Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1.03	-0.32	6.57	19	19	38	39	77	104	94
Consolidated Net Income / (Loss)	2.39	-0.87	6.57	19	22	43	51	97	131	122
Net Income / (Loss) Continuing Operations	2.39	-0.87	6.57	19	22	43	51	97	131	122
Total Pre-Tax Income	2.98	-0.33	7.38	19	19	43	67	116	166	135
Total Operating Income	3.49	0.70	6.47	18	21	39	59	96	151	109
Total Gross Profit	13	17	34	51	70	115	184	276	392	400
Total Revenue	27	37	75	108	157	260	389	558	782	901
Operating Revenue	27	37	75	108	157	260	389	558	782	901
Total Cost of Revenue	14	19	40	57	87	145	205	282	391	501
Operating Cost of Revenue	14	19	40	57	87	145	205	282	391	501
Total Operating Expenses	9.84	17	28	33	48	76	125	180	241	291
Selling, General & Admin Expense	2.67	5.89	7.99	8.06	12	15	22	41	70	69
Marketing Expense	3.91	5.50	9.61	12	17	27	40	47	65	77
Research & Development Expense	3.26	5.14	10	13	19	34	62	93	105	145
Total Other Income / (Expense), net	-0.51	-1.03	0.91	1.15	-2.20	4.35	8.33	20	15	26
Interest Expense	0.52	1.07	0.50	0.75	0.98	0.77	1.66	2.68	4.15	6.96
Interest & Investment Income	0.02	0.05	0.15	0.50	1.55	5.14	13	18	10	25
Other Income / (Expense), net	-	-	1.26	1.39	-2.77	-0.02	-3.42	4.75	9.10	7.79
Income Tax Expense	0.60	0.55	0.81	-0.52	-2.38	0.13	17	19	35	13
Net Income / (Loss) Attributable to Noncontrolling Interest	1.36	-0.55	0.00	0.56	2.90	5.16	11	20	28	28
Basic Earnings per Share	$0.30	($0.05)	$0.42	$1.12	$0.34	$0.65	$0.66	$1.29	$1.67	$1.47
Weighted Average Basic Shares Outstanding	2.18M	6.87M	15.79M	16.80M	54.70M	57.65M	59.24M	60.16M	62.21M	64.18M
Diluted Earnings per Share	$0.18	($0.05)	$0.37	$0.99	$0.30	$0.58	$0.59	$1.16	$1.53	$1.37
Weighted Average Diluted Shares Outstanding	3.79M	6.87M	17.91M	19.14M	63.55M	65.36M	65.34M	64.87M	66.24M	67.31M
Weighted Average Basic & Diluted Shares Outstanding	-	12.99M	15.70M	18.14M	18.74M	19.58M	59.70M	61.10M	63.13M	65.73M

This table shows ACM Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	18	17	24	31	31	20	30	36	8.05	17	89
Consolidated Net Income / (Loss)	23	22	31	39	39	25	36	46	14	26	122
Net Income / (Loss) Continuing Operations	23	22	31	39	39	25	36	46	14	26	122
Total Pre-Tax Income	31	26	41	43	56	27	38	49	21	30	136
Total Operating Income	23	25	38	44	44	26	32	29	23	36	50
Total Gross Profit	79	79	97	105	111	83	104	113	100	107	135
Total Revenue	170	152	202	204	223	172	215	269	244	231	293
Operating Revenue	170	152	202	204	223	172	215	269	244	231	293
Total Cost of Revenue	91	73	106	99	113	90	111	156	145	124	158
Operating Cost of Revenue	91	73	106	99	113	90	111	156	145	124	158
Total Operating Expenses	56	54	59	61	67	57	73	84	77	71	85
Selling, General & Admin Expense	14	16	16	17	21	13	17	22	17	14	19
Marketing Expense	9.44	14	17	16	18	16	22	22	16	21	24
Research & Development Expense	32	24	26	28	28	28	34	40	44	37	42
Total Other Income / (Expense), net	8.05	1.23	3.14	-1.51	12	1.39	6.47	20	-2.26	-6.17	86
Interest Expense	0.70	0.78	0.93	1.21	1.23	1.56	1.76	1.85	1.79	1.93	2.06
Interest & Investment Income	8.30	1.25	1.69	4.28	3.14	4.29	5.79	6.77	8.08	6.47	28
Other Income / (Expense), net	0.46	0.76	2.39	-4.58	11	-1.34	2.44	15	-8.55	-11	60
Income Tax Expense	8.13	4.37	9.34	4.01	17	2.15	1.89	2.69	6.57	3.77	13
Net Income / (Loss) Attributable to Noncontrolling Interest	5.60	4.66	7.19	7.77	8.03	4.63	6.51	11	6.16	8.93	33
Basic Earnings per Share	$0.29	$0.28	$0.39	$0.49	$0.51	$0.32	$0.47	$0.56	$0.12	$0.26	$1.31
Weighted Average Basic Shares Outstanding	60.16M	61.37M	62.18M	62.50M	62.21M	63.27M	63.97M	64.38M	64.18M	65.80M	67.89M
Diluted Earnings per Share	$0.29	$0.26	$0.35	$0.45	$0.47	$0.30	$0.44	$0.52	$0.11	$0.24	$1.23
Weighted Average Diluted Shares Outstanding	64.87M	66.24M	67.06M	66.67M	66.24M	66.95M	67.46M	68.41M	67.31M	69.77M	71.84M
Weighted Average Basic & Diluted Shares Outstanding	61.10M	62.01M	62.47M	62.63M	63.13M	63.86M	64.18M	64.88M	65.73M	66.22M	69.65M

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	5.72	7.56	9.96	91	-46	491	-315	-65	228	355
Net Cash From Operating Activities	-7.35	-8.10	6.91	9.40	-14	-40	-62	-75	152	-10
Net Cash From Continuing Operating Activities	-3.70	-8.10	6.91	9.40	-14	-40	-62	-75	152	-10
Net Income / (Loss) Continuing Operations	2.39	-0.87	6.57	19	22	43	51	97	131	122
Consolidated Net Income / (Loss)	-2.39	-0.87	6.57	19	22	43	51	97	131	122
Depreciation Expense	0.19	0.27	0.42	0.79	1.06	2.35	5.37	8.09	9.97	16
Non-Cash Adjustments To Reconcile Net Income	-1.99	1.59	3.24	4.40	-0.26	37	118	49	137	-19
Changes in Operating Assets and Liabilities, net	0.49	-9.09	-3.32	-15	-36	-123	-236	-229	-126	-130
Net Cash From Investing Activities	-0.81	-24	-2.07	-5.53	-70	-11	-266	-6.75	-12	-390
Net Cash From Continuing Investing Activities	-0.81	-24	-2.07	-5.53	-70	-11	-266	-6.75	-12	-390
Purchase of Property, Plant & Equipment	-0.80	-0.65	-1.83	-0.97	-5.21	-9.15	-91	-62	-82	-56
Acquisitions	-0.02	-1.32	-0.24	-0.15	-0.32	-0.56	-1.43	-2.46	-3.49	-1.37
Purchase of Investments	0.00	-0.95	0.00	-4.41	-15	-1.57	-5.28	-26	-26	-0.48
Sale and/or Maturity of Investments	-	-	0.00	0.00	0.56	0.00	4.58	110	175	56
Other Investing Activities, net	0.00	-21	0.00	0.00	-50	0.00	-172	-26	-75	-389
Net Cash From Financing Activities	11	39	5.12	87	33	539	46	19	92	742
Net Cash From Continuing Financing Activities	11	39	5.12	87	33	539	46	19	92	742
Repayment of Debt	-7.72	-11	-13	-14	-22	-42	-11	-57	-42	-108
Repurchase of Common Equity	-	-	0.00	-2.83	-	-	-	0.00	0.00	-6.99
Payment of Dividends	-	-	-	-	-	-	0.00	-3.95	-6.90	-7.58
Issuance of Debt	5.92	11	18	18	52	30	56	74	130	207
Issuance of Common Equity	0.00	33	0.00	86	0.00	546	-	0.00	0.00	623
Other Financing Activities, net	3.31	-0.14	0.53	-0.26	2.75	5.25	1.31	6.14	11	35
Effect of Exchange Rate Changes	-0.32	0.66	-	-0.58	4.57	3.91	-33	-1.74	-4.84	13
Cash Interest Paid	0.18	0.28	0.50	0.75	0.98	0.77	1.66	2.68	4.15	6.96
Cash Income Taxes Paid	-	-	0.00	1.16	4.97	1.13	3.59	26	11	32

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-24	29	113	10	76	57	-15	614	-301	128	96
Net Cash From Operating Activities	-38	-9.65	62	12	89	5.28	-45	-4.63	34	-30	-6.36
Net Cash From Continuing Operating Activities	-38	-9.65	62	12	89	5.28	-45	-4.63	34	-30	-6.36
Net Income / (Loss) Continuing Operations	23	22	31	39	39	25	36	46	14	26	122
Consolidated Net Income / (Loss)	23	22	31	39	39	25	36	46	14	26	122
Depreciation Expense	2.07	2.52	2.17	2.39	2.89	3.02	3.34	4.10	5.87	5.47	6.30
Non-Cash Adjustments To Reconcile Net Income	-17	24	42	24	48	13	-12	-20	0.22	-4.67	-77
Changes in Operating Assets and Liabilities, net	-47	-58	-14	-54	-1.41	-36	-73	-35	14	-57	-58
Net Cash From Investing Activities	0.54	12	20	-23	-21	-17	-14	-11	-348	-9.79	-70
Net Cash From Continuing Investing Activities	0.54	12	20	-23	-21	-17	-14	-11	-348	-9.79	-70
Purchase of Property, Plant & Equipment	-12	-25	-13	-33	-11	-17	-15	-11	-14	-22	-65
Acquisitions	-0.85	-0.67	-0.48	-0.83	-1.50	-0.38	-0.41	0.00	-0.59	-0.24	-0.24
Purchase of Investments	-1.27	-7.40	-1.37	-	-17	0.00	-	-0.48	-0.01	-0.36	-4.34
Sale and/or Maturity of Investments	18	91	47	21	16	10	17	10	19	13	25
Other Investing Activities, net	-3.19	-45	-13	-11	-5.92	-10	-16	-10	-352	0.00	-25
Net Cash From Financing Activities	12	27	31	19	15	67	44	627	4.37	163	169
Net Cash From Continuing Financing Activities	12	27	31	19	15	67	44	627	4.37	163	169
Repayment of Debt	-5.85	-1.48	-2.92	-33	-4.84	-25	-15	-37	-30	-42	-82
Issuance of Debt	17	24	33	58	16	70	65	45	28	78	90
Issuance of Common Equity	-	0.00	-	-	-	0.14	0.10	623	-	110	148
Other Financing Activities, net	0.85	4.80	1.64	0.05	4.61	23	0.85	4.31	6.87	18	13
Effect of Exchange Rate Changes	1.81	-0.55	0.21	2.97	-7.46	0.87	0.65	3.43	7.88	4.11	3.30
Cash Interest Paid	0.70	0.78	0.93	1.21	1.23	1.56	1.76	1.85	1.79	1.93	2.06
Cash Income Taxes Paid	9.63	0.00	9.11	0.69	1.42	11	13	6.55	2.42	2.06	28

This table presents ACM Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	44	68	103	218	341	1,052	1,236	1,491	1,856	2,872
Total Current Assets	40	63	96	198	261	953	964	1,176	1,483	2,437
Cash & Equivalents	10	18	27	58	72	563	248	182	407	757
Restricted Cash	-	-	0.00	60	-	0.52	0.50	1.08	3.87	8.59
Short-Term Investments	-	-	-	0.00	28	29	20	21	19	36
Accounts Receivable	18	29	28	34	66	125	216	326	430	555
Inventories, net	12	15	39	45	89	218	393	545	598	703
Prepaid Expenses	0.72	0.55	1.99	2.05	5.89	14	16	20	7.51	11
Other Current Assets	0.05	0.05	-	-	-	2.38	70	81	17	367
Plant, Property, & Equipment, net	2.26	2.34	3.71	3.62	8.19	14	83	202	269	315
Total Noncurrent Assets	1.86	2.64	3.31	16	72	85	189	113	103	121
Long-Term Investments	0.00	1.24	1.36	5.93	6.34	13	17	28	37	66
Intangible Assets	0.02	0.11	0.27	0.34	0.55	0.48	1.26	2.54	3.46	2.85
Noncurrent Deferred & Refundable Income Taxes	1.84	1.29	1.64	5.33	11	13	6.70	20	15	29
Other Noncurrent Operating Assets	-	0.00	0.04	4.08	54	59	163	62	48	22
Total Liabilities & Shareholders' Equity	44	68	103	218	341	1,052	1,236	1,491	1,856	2,872
Total Liabilities	24	28	51	60	133	241	423	565	760	942
Total Current Liabilities	17	22	46	54	103	206	396	501	641	746
Short-Term Debt	4.77	5.10	9.45	14	28	12	58	38	77	109
Accounts Payable	9.14	13	27	26	54	133	168	256	277	398
Current Deferred Revenue	0.22	0.14	-	9.13	1.34	56	158	185	252	205
Current Deferred & Payable Income Tax Liabilities	0.04	0.04	1.19	3.13	0.03	0.25	3.47	6.40	13	0.99
Other Current Liabilities	0.00	3.08	8.42	1.36	19	4.60	8.07	15	22	33
Total Noncurrent Liabilities	6.88	6.22	4.58	6.72	30	35	27	64	119	196
Long-Term Debt	-	-	-	0.00	18	23	19	54	106	179
Other Noncurrent Operating Liabilities	6.88	6.22	4.58	6.72	11	10	8.43	10	13	17
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2.49	40	52	97	208	812	812	926	1,096	1,931
Total Preferred & Common Equity	-2.43	40	52	97	141	676	675	767	905	1,464
Total Common Equity	-2.44	40	52	97	141	676	675	767	905	1,464
Common Stock	7.62	50	57	83	102	595	604	630	677	1,116
Retained Earnings	-9.64	-9.96	-3.39	16	34	64	94	157	260	350
Accumulated Other Comprehensive Income / (Loss)	-0.41	0.12	-0.86	-1.68	4.86	9.11	-41	-49	-63	-36
Other Equity Adjustments	-	-	-	-	-	8.31	17	30	31	34
Noncontrolling Interest	4.92	-	-	0.00	67	135	137	159	191	466

This table presents ACM Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	1,313	1,317	1,410	1,557	1,668	1,794	1,934	2,040	2,771	3,066	3,399
Total Current Assets	994	997	1,116	1,229	1,343	1,445	1,548	1,646	2,358	2,619	2,875
Cash & Equivalents	260	257	207	211	324	333	457	442	1,059	872	969
Restricted Cash	0.46	0.58	0.56	0.81	0.88	1.78	11	11	8.43	22	21
Short-Term Investments	13	6.38	22	19	20	20	18	21	40	35	105
Accounts Receivable	222	236	286	349	350	430	424	478	528	581	605
Inventories, net	473	471	507	581	603	629	610	648	676	738	783
Prepaid Expenses	19	19	18	20	19	11	11	14	15	13	26
Other Current Assets	5.31	6.00	76	48	27	20	17	31	31	358	365
Plant, Property, & Equipment, net	150	159	191	219	229	250	277	291	297	324	385
Total Noncurrent Assets	169	161	103	109	96	99	109	103	116	123	140
Long-Term Investments	17	16	22	31	32	34	55	57	64	68	89
Intangible Assets	1.23	2.11	2.16	2.80	2.84	2.84	3.00	2.85	2.71	2.72	2.52
Noncurrent Deferred & Refundable Income Taxes	13	11	16	21	21	13	16	22	27	30	26
Other Noncurrent Operating Assets	138	132	63	53	40	49	35	21	23	21	22
Total Liabilities & Shareholders' Equity	1,313	1,317	1,410	1,557	1,668	1,794	1,934	2,040	2,771	3,066	3,399
Total Liabilities	480	484	532	596	666	725	778	848	885	982	994
Total Current Liabilities	450	456	482	533	586	610	629	671	678	746	786
Short-Term Debt	59	57	41	61	74	64	93	115	94	107	148
Accounts Payable	188	179	225	259	275	302	255	295	339	401	419
Current Deferred Revenue	185	201	196	187	211	226	252	235	219	180	181
Current Deferred & Payable Income Tax Liabilities	8.58	10	11	11	11	6.80	6.17	0.25	0.00	25	3.63
Other Current Liabilities	9.79	9.49	9.36	15	15	11	23	25	26	33	34
Total Noncurrent Liabilities	30	27	50	63	80	115	150	177	208	237	208
Long-Term Debt	18	16	40	53	71	106	135	163	193	221	193
Other Noncurrent Operating Liabilities	12	11	10	9.30	9.18	8.99	15	14	14	16	15
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	833	833	878	961	1,001	1,069	1,155	1,192	1,885	2,083	2,405
Total Preferred & Common Equity	692	692	729	796	833	888	949	986	1,433	1,582	1,860
Total Common Equity	692	692	729	796	833	888	949	986	1,433	1,582	1,860
Common Stock	606	613	620	647	659	670	700	705	1,105	1,195	1,362
Retained Earnings	101	124	152	174	198	229	280	310	346	368	457
Accumulated Other Comprehensive Income / (Loss)	-33	-62	-60	-55	-55	-41	-62	-59	-49	-15	7.42
Other Equity Adjustments	17	17	17	30	30	30	31	31	31	34	34
Noncontrolling Interest	141	141	149	165	168	181	206	205	453	502	545

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	64,876,451.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	64,876,451.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	1.45
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	2.79	0.49	5.76	18	24	39	44	80	119	99
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	4.98%	7.84%	9.32%	4.45%
Earnings before Interest and Taxes (EBIT)	3.49	0.70	7.73	19	19	39	56	101	160	117
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3.68	0.97	8.14	20	20	41	61	109	170	134
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-10	-1.49	4.12	-76	-55	-317	-103	94	-441
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	15	26	33	47	148	241	603	786	811	1,351
Increase / (Decrease) in Invested Capital	0.00	11	7.25	14	100	94	362	183	25	540
Book Value per Share	($1.12)	$2.60	$3.27	$5.35	$7.64	$34.66	$11.35	$12.66	$14.44	$22.57
Tangible Book Value per Share	($1.13)	$2.59	$3.25	$5.33	$7.61	$34.64	$11.33	$12.62	$14.39	$22.53
Total Capital	25	45	62	171	254	847	889	1,018	1,279	2,219
Total Debt	4.77	5.10	9.45	14	46	35	77	92	183	288
Total Long-Term Debt	0.00	0.00	0.00	0.00	18	23	19	54	106	179
Net Debt	-5.35	-14	-19	-110	-61	-570	-209	-140	-285	-579
Capital Expenditures (CapEx)	0.79	0.65	1.83	0.97	5.21	9.15	91	62	82	56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	18	29	32	41	85	166	357	509	489	999
Debt-free Net Working Capital (DFNWC)	28	46	59	159	185	759	626	714	919	1,800
Net Working Capital (NWC)	23	41	50	145	158	747	568	675	842	1,691
Net Nonoperating Expense (NNE)	0.41	1.36	-0.81	-1.18	2.47	-4.34	-6.25	-17	-12	-23
Net Nonoperating Obligations (NNO)	-5.35	-14	-19	-110	-61	-570	-209	-140	-285	-579
Total Depreciation and Amortization (D&A)	0.19	0.27	0.42	0.79	1.06	2.35	5.37	8.09	9.97	16
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.10	($0.02)	$0.14	$0.37	$0.34	$0.65	$0.66	$1.29	$1.67	$1.47
Adjusted Weighted Average Basic Shares Outstanding	6.53M	20.60M	47.37M	50.40M	54.70M	57.65M	59.24M	60.16M	62.21M	64.18M
Adjusted Diluted Earnings per Share	$0.06	($0.02)	$0.12	$0.33	$0.30	$0.58	$0.59	$1.16	$1.53	$1.37
Adjusted Weighted Average Diluted Shares Outstanding	11.38M	20.60M	53.74M	57.41M	63.55M	65.36M	65.34M	64.87M	66.24M	67.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.37	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	38.98M	42.53M	54.41M	56.23M	58.74M	59.70M	61.10M	63.13M	65.73M
Normalized Net Operating Profit after Tax (NOPAT)	2.79	0.49	5.76	12	15	39	44	80	119	99
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	64,876,451.00	65,727,594.00	66,224,872.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	64,876,451.00	65,727,594.00	66,224,872.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	0.12	0.26	1.34
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	56.92%	104.95%	40.05%	21.00%	31.21%	13.24%	6.37%	31.96%	-	34.18%	36.01%
EBITDA Growth	99.46%	128.10%	11.33%	29.50%	121.67%	-3.71%	-11.09%	14.95%	-	12.70%	209.15%
EBIT Growth	103.27%	141.01%	12.25%	30.45%	128.79%	-5.99%	-14.63%	11.52%	-	4.25%	220.94%
NOPAT Growth	23.44%	214.07%	16.87%	23.48%	75.94%	12.67%	3.96%	-31.71%	-	33.27%	48.74%
Net Income Growth	64.27%	146.48%	-6.54%	24.77%	67.85%	13.22%	15.51%	19.98%	-	4.89%	237.06%
EPS Growth	45.00%	136.36%	-14.63%	15.38%	62.07%	15.38%	25.71%	15.56%	-	-20.00%	179.55%
Operating Cash Flow Growth	-4,712.17%	68.36%	442.70%	166.83%	331.00%	154.74%	-172.90%	-138.82%	-	-659.22%	85.84%
Free Cash Flow Firm Growth	52.40%	7.97%	21.83%	47.60%	103.25%	97.29%	-20.94%	-19.37%	-	-11,448.00%	-315.23%
Invested Capital Growth	30.31%	31.36%	22.99%	20.33%	3.19%	3.49%	21.97%	17.76%	-	68.01%	66.24%
Revenue Q/Q Growth	1.04%	-10.64%	33.04%	0.74%	9.56%	-22.88%	24.96%	24.97%	-	-5.39%	26.66%
EBITDA Q/Q Growth	-20.13%	10.07%	47.84%	-0.37%	36.72%	-52.19%	36.51%	28.83%	-	52.00%	274.44%
EBIT Q/Q Growth	-21.51%	9.07%	53.83%	-0.94%	37.66%	-55.18%	39.70%	29.40%	-	75.84%	330.07%
NOPAT Q/Q Growth	-46.55%	21.57%	37.55%	38.16%	-23.85%	-22.15%	26.92%	-9.24%	-	100.75%	41.65%
Net Income Q/Q Growth	-24.83%	-5.18%	42.13%	23.16%	1.12%	-36.04%	45.00%	27.92%	-	84.60%	365.98%
EPS Q/Q Growth	-25.64%	-10.34%	34.62%	28.57%	4.44%	-36.17%	46.67%	18.18%	-	118.18%	412.50%
Operating Cash Flow Q/Q Growth	-115.16%	74.84%	738.31%	-80.66%	643.68%	-94.04%	-950.08%	89.70%	-	-187.08%	78.48%
Free Cash Flow Firm Q/Q Growth	16.33%	-4.62%	33.60%	9.85%	105.20%	-187.01%	-2,867.95%	11.03%	-	-3.16%	-6.72%
Invested Capital Q/Q Growth	11.20%	3.50%	-5.35%	10.45%	-4.63%	3.80%	11.55%	6.64%	-	4.69%	10.38%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.43%	51.99%	47.80%	51.40%	49.59%	47.90%	48.50%	42.04%	-	46.37%	45.96%
EBITDA Margin	15.21%	18.73%	20.82%	20.59%	25.69%	15.93%	17.40%	17.93%	-	13.38%	39.55%
Operating Margin	13.72%	16.58%	18.57%	21.66%	19.68%	14.96%	14.72%	10.75%	-	15.64%	16.98%
EBIT Margin	13.99%	17.08%	19.75%	19.42%	24.40%	14.18%	15.85%	16.41%	-	11.01%	37.40%
Profit (Net Income) Margin	13.68%	14.52%	15.51%	18.96%	17.50%	14.51%	16.84%	17.24%	-	11.34%	41.74%
Tax Burden Percent	74.13%	83.49%	77.08%	90.61%	69.31%	92.07%	95.04%	94.52%	-	87.43%	90.07%
Interest Burden Percent	131.89%	101.81%	101.89%	107.76%	103.50%	111.19%	111.80%	111.14%	-	117.80%	123.90%
Effective Tax Rate	25.87%	16.51%	22.92%	9.39%	30.69%	7.93%	4.96%	5.48%	-	12.57%	9.93%
Return on Invested Capital (ROIC)	8.17%	12.28%	14.22%	18.38%	13.36%	13.35%	13.34%	9.66%	-	11.64%	12.70%
ROIC Less NNEP Spread (ROIC-NNEP)	4.75%	11.71%	13.12%	19.08%	9.31%	12.79%	10.80%	6.20%	-	12.74%	-1.43%
Return on Net Nonoperating Assets (RNNOA)	-0.96%	-2.36%	-3.14%	-3.82%	-1.96%	-2.79%	-2.38%	-2.31%	-	-3.87%	0.43%
Return on Equity (ROE)	7.22%	9.93%	11.08%	14.56%	11.41%	10.56%	10.96%	7.34%	-	7.78%	13.13%
Cash Return on Invested Capital (CROIC)	-14.82%	-13.94%	-6.48%	-4.77%	11.78%	11.28%	-5.38%	-4.21%	-	-41.28%	-39.97%
Operating Return on Assets (OROA)	5.72%	7.57%	9.18%	8.83%	11.40%	6.52%	6.97%	6.33%	-	4.23%	14.27%
Return on Assets (ROA)	5.60%	6.43%	7.21%	8.63%	8.18%	6.67%	7.41%	6.65%	-	4.36%	15.93%
Return on Common Equity (ROCE)	5.99%	8.24%	9.21%	12.09%	9.43%	8.71%	9.09%	5.77%	-	6.08%	10.39%
Return on Equity Simple (ROE_SIMPLE)	0.00%	13.81%	12.94%	13.00%	0.00%	14.14%	0.00%	0.00%	-	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	17	21	29	40	30	24	30	27	16	32	45
NOPAT Margin	10.17%	13.84%	14.31%	19.63%	13.64%	13.77%	13.99%	10.16%	-	13.68%	15.30%
Net Nonoperating Expense Percent (NNEP)	3.42%	0.57%	1.10%	-0.70%	4.05%	0.55%	2.54%	3.46%	-	-1.10%	14.12%
Return On Investment Capital (ROIC_SIMPLE)	1.70%	1.96%	-	-	2.38%	1.72%	2.05%	1.26%	0.71%	1.31%	1.63%
Cost of Revenue to Revenue	53.57%	48.01%	52.20%	48.60%	50.41%	52.10%	51.50%	57.96%	-	53.63%	54.04%
SG&A Expenses to Revenue	8.10%	10.38%	7.95%	8.36%	9.26%	7.50%	7.82%	8.27%	-	5.98%	6.43%
R&D to Revenue	19.06%	15.72%	12.83%	13.65%	12.42%	15.96%	15.70%	14.73%	-	15.80%	14.43%
Operating Expenses to Revenue	32.70%	35.41%	29.23%	29.73%	29.90%	32.94%	33.79%	31.29%	-	30.73%	28.98%
Earnings before Interest and Taxes (EBIT)	24	26	40	40	55	24	34	44	14	25	110
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	26	29	42	42	57	27	37	48	20	31	116
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.54	2.22	1.72	1.43	1.05	1.55	1.68	1.75	-	1.64	4.52
Price to Tangible Book Value (P/TBV)	1.55	2.23	1.72	1.43	1.05	1.56	1.68	1.76	-	1.64	4.52
Price to Revenue (P/Rev)	2.12	2.78	2.06	1.74	1.21	1.84	2.03	2.85	-	2.69	8.10
Price to Earnings (P/E)	15.31	20.15	16.82	14.05	9.13	13.83	14.75	21.45	-	28.42	55.94
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Earnings Yield	6.53%	4.96%	5.95%	7.12%	10.96%	7.23%	6.78%	4.66%	-	3.52%	1.79%
Enterprise Value to Invested Capital (EV/IC)	1.53	2.19	1.78	1.45	1.05	1.62	1.71	2.08	-	1.71	5.19
Enterprise Value to Revenue (EV/Rev)	2.16	2.81	1.97	1.69	1.09	1.70	1.97	2.36	-	2.52	7.81
Enterprise Value to EBITDA (EV/EBITDA)	11.07	14.30	10.60	8.88	5.01	8.08	9.78	12.19	-	17.65	37.62
Enterprise Value to EBIT (EV/EBIT)	11.96	15.40	11.37	9.51	5.32	8.62	10.52	13.23	-	20.46	41.85
Enterprise Value to NOPAT (EV/NOPAT)	15.06	18.91	13.84	11.55	7.15	11.22	13.04	18.57	-	22.64	66.23
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	48.25	5.59	8.16	26.39	46.90	-	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	9.06	14.63	0.00	0.00	-	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.10	0.12	0.14	0.16	0.17	0.20	0.23	0.15	-	0.16	0.14
Long-Term Debt to Equity	0.06	0.06	0.07	0.10	0.10	0.12	0.14	0.10	-	0.11	0.08
Financial Leverage	-0.20	-0.20	-0.24	-0.20	-0.21	-0.22	-0.22	-0.37	-	-0.30	-0.30
Leverage Ratio	1.57	1.60	1.63	1.65	1.66	1.65	1.69	1.55	-	1.54	1.51
Compound Leverage Factor	2.07	1.63	1.66	1.77	1.71	1.83	1.89	1.72	-	1.82	1.87
Debt to Total Capital	9.04%	10.66%	12.64%	13.76%	14.30%	16.45%	18.92%	13.21%	-	13.61%	12.41%
Short-Term Debt to Total Capital	3.74%	5.70%	6.47%	5.20%	6.04%	6.72%	7.83%	4.31%	-	4.45%	5.39%
Long-Term Debt to Total Capital	5.30%	4.97%	6.18%	8.56%	8.25%	9.73%	11.09%	8.90%	-	9.16%	7.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Noncontrolling Interests to Total Capital	15.59%	15.30%	14.67%	14.59%	14.96%	14.91%	13.96%	20.83%	-	20.81%	19.85%
Common Equity to Total Capital	75.36%	74.03%	72.68%	71.65%	70.74%	68.64%	67.12%	65.95%	-	65.58%	67.74%
Debt to EBITDA	0.85	0.92	1.12	1.23	1.08	1.35	1.69	1.68	-	2.39	1.58
Net Debt to EBITDA	-1.29	-1.18	-1.79	-1.58	-1.68	-1.86	-1.54	-5.18	-	-4.88	-3.92
Long-Term Debt to EBITDA	0.50	0.43	0.55	0.77	0.62	0.80	0.99	1.13	-	1.61	0.90
Debt to NOPAT	1.15	1.22	1.47	1.60	1.53	1.87	2.26	2.56	-	3.07	2.79
Net Debt to NOPAT	-1.76	-1.56	-2.34	-2.05	-2.39	-2.57	-2.05	-7.89	-	-6.26	-6.90
Long-Term Debt to NOPAT	0.68	0.57	0.72	1.00	0.89	1.10	1.32	1.73	-	2.07	1.58
Altman Z-Score	2.38	2.93	2.49	2.27	2.01	2.37	2.41	2.97	-	2.82	6.41
Noncontrolling Interest Sharing Ratio	17.03%	17.03%	16.88%	16.95%	17.31%	17.52%	17.03%	21.44%	-	21.87%	20.86%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.35	2.31	2.29	2.37	2.31	2.46	2.45	3.48	-	3.51	3.66
Quick Ratio	1.06	1.09	1.18	1.28	1.34	1.43	1.40	2.40	-	2.00	2.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-165	-173	-115	-104	5.38	-4.68	-139	-124	-524	-541	-577
Operating Cash Flow to CapEx	-310.78%	-37.96%	470.41%	36.62%	776.06%	31.58%	-304.79%	-41.99%	-	-133.05%	-9.77%
Free Cash Flow to Firm to Interest Expense	-237.41	-221.09	-123.34	-85.78	4.38	-3.01	-79.12	-66.82	-	-279.82	-280.35
Operating Cash Flow to Interest Expense	-55.03	-12.32	66.08	9.86	72.15	3.39	-25.56	-2.50	-	-15.28	-3.09
Operating Cash Flow Less CapEx to Interest Expense	-72.73	-44.79	52.04	-17.07	62.85	-7.35	-33.94	-8.45	-	-26.77	-34.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.44	0.46	0.46	0.47	0.46	0.44	0.39	-	0.38	0.38
Accounts Receivable Turnover	2.06	2.23	2.37	2.04	2.07	2.07	1.97	1.84	-	1.91	1.92
Inventory Turnover	0.60	0.61	0.65	0.65	0.68	0.68	0.66	0.72	-	0.79	0.81
Fixed Asset Turnover	3.92	3.45	3.58	3.31	3.32	3.24	3.14	3.22	-	3.20	3.07
Accounts Payable Turnover	1.33	1.43	1.54	1.40	1.46	1.59	1.45	1.46	-	1.63	1.63
Days Sales Outstanding (DSO)	177.21	164.03	154.29	179.17	176.31	175.91	185.37	198.65	-	191.06	190.53
Days Inventory Outstanding (DIO)	608.47	600.78	559.92	561.68	534.27	533.54	553.56	507.45	-	459.28	448.19
Days Payable Outstanding (DPO)	275.25	254.52	236.74	260.21	249.18	230.04	252.52	249.16	-	223.33	223.79
Cash Conversion Cycle (CCC)	510.43	510.29	477.47	480.64	461.41	479.41	486.41	456.94	-	427.01	414.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	786	813	770	850	811	842	939	1,001	1,351	1,414	1,561
Invested Capital Turnover	0.80	0.89	0.99	0.94	0.98	0.97	0.95	0.95	-	0.85	0.83
Increase / (Decrease) in Invested Capital	183	194	144	144	25	28	169	151	540	573	622
Enterprise Value (EV)	1,203	1,783	1,367	1,230	852	1,366	1,607	2,080	-	2,419	8,104
Market Capitalization	1,184	1,766	1,430	1,268	946	1,473	1,654	2,511	-	2,586	8,403
Book Value per Share	$12.66	$12.97	$13.44	$14.22	$14.44	$15.03	$15.45	$22.32	$22.57	$24.06	$28.09
Tangible Book Value per Share	$12.62	$12.93	$13.39	$14.17	$14.39	$14.99	$15.40	$22.28	$22.53	$24.02	$28.05
Total Capital	1,018	1,075	1,146	1,240	1,279	1,383	1,470	2,172	2,219	2,412	2,746
Total Debt	92	115	145	171	183	227	278	287	288	328	341
Total Long-Term Debt	54	53	71	106	106	135	163	193	179	221	193
Net Debt	-140	-147	-231	-219	-285	-314	-253	-884	-579	-669	-844
Capital Expenditures (CapEx)	12	25	13	33	11	17	15	11	14	22	65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	509	527	487	544	489	526	616	667	999	1,052	1,141
Debt-free Net Working Capital (DFNWC)	714	757	831	900	919	1,012	1,090	1,774	1,800	1,981	2,237
Net Working Capital (NWC)	675	696	757	835	842	919	975	1,680	1,691	1,874	2,089
Net Nonoperating Expense (NNE)	-5.97	-1.03	-2.42	1.36	-8.62	-1.28	-6.15	-19	1.54	5.40	-77
Net Nonoperating Obligations (NNO)	-140	-147	-231	-219	-285	-314	-253	-884	-579	-669	-844
Total Depreciation and Amortization (D&A)	2.07	2.52	2.17	2.39	2.89	3.02	3.34	4.10	5.87	5.47	6.30
Debt-free, Cash-free Net Working Capital to Revenue	91.28%	82.84%	70.16%	74.65%	62.49%	65.53%	75.54%	75.73%	-	109.57%	109.93%
Debt-free Net Working Capital to Revenue	127.94%	119.15%	119.83%	123.43%	117.56%	126.13%	133.68%	201.51%	-	206.30%	215.51%
Net Working Capital to Revenue	121.11%	109.51%	109.15%	114.58%	107.68%	114.55%	119.56%	190.87%	-	195.13%	201.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.29	$0.28	$0.39	$0.49	$0.51	$0.32	$0.47	$0.56	$0.12	$0.26	$1.31
Adjusted Weighted Average Basic Shares Outstanding	60.16M	61.37M	62.18M	62.50M	62.21M	63.27M	63.97M	64.38M	64.18M	65.80M	67.89M
Adjusted Diluted Earnings per Share	$0.29	$0.26	$0.35	$0.45	$0.47	$0.30	$0.44	$0.52	$0.11	$0.24	$1.23
Adjusted Weighted Average Diluted Shares Outstanding	64.87M	66.24M	67.06M	66.67M	66.24M	66.95M	67.46M	68.41M	67.31M	69.77M	71.84M
Adjusted Basic & Diluted Earnings per Share	$0.29	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	61.10M	62.01M	62.47M	62.63M	63.13M	63.86M	64.18M	64.88M	65.73M	66.22M	69.65M
Normalized Net Operating Profit after Tax (NOPAT)	17	21	29	40	30	24	30	27	16	32	45
Normalized NOPAT Margin	10.17%	13.84%	14.31%	19.63%	13.64%	13.77%	13.99%	10.16%	-	13.68%	15.30%
Pre Tax Income Margin	18.45%	17.39%	20.12%	20.92%	25.25%	15.76%	17.72%	18.24%	-	12.97%	46.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	34.19	33.19	42.90	32.78	44.40	15.68	19.43	23.86	-	13.18	53.20
NOPAT to Interest Expense	24.86	26.90	31.09	33.14	24.83	15.23	17.14	14.77	-	16.36	21.76
EBIT Less CapEx to Interest Expense	16.48	0.73	28.85	5.85	35.10	4.95	11.04	17.91	-	1.69	21.58
NOPAT Less CapEx to Interest Expense	7.16	-5.56	17.04	6.21	15.53	4.50	8.76	8.82	-	4.88	-9.86
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	4.08%	0.00%	0.00%	0.00%	5.26%	0.00%	0.00%	5.16%	-	0.00%	0.00%
Augmented Payout Ratio	4.08%	0.00%	0.00%	0.00%	5.26%	0.00%	0.00%	5.16%	-	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

ACM Research (NASDAQ: ACMR) showed a sharp rebound in profitability and cash generation in Q1 2026 versus the prior few quarters, but the balance sheet also reflects a large increase in equity and financing activity that investors should watch closely.

Revenue growth accelerated again in Q1 2026. Sales rose to $231.3 million, up from $244.4 million in Q4 2025 but above the $172.3 million level in Q1 2025 and far ahead of Q1 2024.
Profitability improved meaningfully year over year. Net income attributable to common shareholders was $17.3 million in Q1 2026, up from $8.0 million in Q4 2025 and $20.4 million in Q1 2025, with operating income at $36.2 million.
Gross margin remained solid. Gross profit was $107.2 million on revenue of $231.3 million, showing the company is still converting a healthy portion of sales into gross profit.
Cash and investments are substantial. ACMR ended Q1 2026 with $872.3 million in cash and equivalents, plus $34.7 million in short-term investments and $68.5 million in long-term investments.
The company maintains a strong equity base. Total common equity was $1.58 billion, while total equity and noncontrolling interests reached $2.08 billion.
Operating income was much stronger than recent low points. Q1 2026 operating income of $36.2 million improved versus $23.0 million in Q4 2025 and was a big rebound from the weak cash flow seen in some prior quarters.
Inventory remains elevated. Inventories were $738.0 million in Q1 2026, compared with $676.4 million in Q3 2025 and $609.6 million in Q1 2025, which could be normal for a hardware/systems business but is worth monitoring.
Accounts receivable are also high. Receivables totaled $581.0 million, suggesting a large amount of sales is still sitting on the balance sheet before being collected.
Operating cash flow was negative in Q1 2026. The company used $29.5 million in operating cash, driven by -$56.6 million in working capital changes.
Debt increased again. Short-term debt was $107.3 million and long-term debt was $220.9 million at the end of Q1 2026, up from prior periods.

Looking at the broader trend, ACM Research has grown revenue substantially from 2023 into 2025 and into Q1 2026, and earnings have improved with that growth. However, the cash flow statement shows the business can swing sharply quarter to quarter because of working capital, capex, and financing activity. In Q1 2026, financing inflows helped offset weak operating cash flow, which means investors should not rely on earnings alone when judging the company’s financial strength.

Bottom line: ACMR appears to be a growing, profitable company with a strong cash position, but investors should keep an eye on inventory, receivables, and the need for external financing to support growth.

08/27/26 01:19 PM ETAI Generated. May Contain Errors.

ACM Research Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ACM Research's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

ACM Research's net income appears to be on an upward trend, with a most recent value of $121.89 million in 2025, rising from $2.39 million in 2016. The previous period was $131.27 million in 2024. Find out what analysts predict for ACM Research in the coming months.

ACM Research's total operating income in 2025 was $109.43 million, based on the following breakdown:

Total Gross Profit: $400.07 million
Total Operating Expenses: $290.64 million

Over the last 9 years, ACM Research's total revenue changed from $27.37 million in 2016 to $901.31 million in 2025, a change of 3,192.9%.

ACM Research's total liabilities were at $941.68 million at the end of 2025, a 23.9% increase from 2024, and a 3,832.2% increase since 2016.

In the past 9 years, ACM Research's cash and equivalents has ranged from $10.12 million in 2016 to $757.37 million in 2025, and is currently $757.37 million as of their latest financial filing in 2025.

Over the last 9 years, ACM Research's book value per share changed from -1.12 in 2016 to 22.57 in 2025, a change of -2,116.6%.

Related Companies

Financial statements for NASDAQ:ACMR last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ACM Research (ACMR) Financials

Financials Breakdown Chart

Key Financial Trends

ACM Research Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ACM Research (ACMR) Financials

Annual Income Statements for ACM Research

Quarterly Income Statements for ACM Research

Annual Cash Flow Statements for ACM Research

Quarterly Cash Flow Statements for ACM Research

Annual Balance Sheets for ACM Research

Quarterly Balance Sheets for ACM Research

Annual Metrics And Ratios for ACM Research

Quarterly Metrics And Ratios for ACM Research

Financials Breakdown Chart

Key Financial Trends

ACM Research Financials - Frequently Asked Questions

When does ACM Research's fiscal year end?

How has ACM Research's net income changed over the last 9 years?

What is ACM Research's operating income?

How has ACM Research's revenue changed over the last 9 years?

How much debt does ACM Research have?

How much cash does ACM Research have?

How has ACM Research's book value per share changed over the last 9 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools